SCHEMBL6071808

SCHEMBL6071808

CCOc1cc2c(c3c1OC(C)(C)C3)C(c1ccc(C(=O)OC)c(N)c1)=NC(C)(C)C2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
MAPT P10636 2/20 0.32
HSD17B10 Q99714 2/20 0.32
GLA P06280 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
ATM Q13315 1/20 0.32
ABL1 P00519 1/20 0.32
IRAK4 Q9NWZ3 2/20 0.31
ALOX15 P16050 1/20 0.31
FFAR4 Q5NUL3 2/20 0.31
JAK2 O60674 2/20 0.31
JAK3 P52333 2/20 0.31
CFTR P13569 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6071761 0.99 GAA (0.33) GAATSHRMAPK1TDP1KDM4E
SCHEMBL6072134 0.92 IRAK4 (0.32) IRAK4EZH2
SCHEMBL6071563 0.91 KDM4E (0.35) GAATSHRKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL6072006 0.91 SSTR5 (0.32) MAPK1KDM4EALDH1A1HPGDMAPT
SCHEMBL6072327 0.90 PDE1A (0.33) TDP1MAPTIRAK4FFAR4EZH2
SCHEMBL6072106 0.90 IDO1 (0.33) TDP1KDM4EALDH1A1MAPTIRAK4
Hydrochloric Acid SCHEMBL6072214 0.90 TDP1 (0.32) GAATSHRTDP1MAPTIRAK4
SCHEMBL6072481 0.90 IDO1 (0.33) TDP1KDM4EALDH1A1MAPTIRAK4
SCHEMBL6071599 0.89 TDP1 (0.32) TDP1IRAK4FFAR4
Hydrochloric Acid SCHEMBL6072515 0.89 TDP1 (0.32) TDP1IRAK4FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106048-A1 Furoisoquinoline derivative and use thereof PASCALI, PETROS P. (CY) 2006-05-18 US disclosed
EP-1541576-A1 FUROISOQUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106048-A1 Furoisoquinoline derivative and use thereof PDE3B, PDE2A, PDE3A GAA 3467/4885TSHR 629/4885MAPK1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.